IBDEI06R ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6655,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,6655,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,6656,0)
 ;;=L03.811^^42^482^11
 ;;^UTILITY(U,$J,358.3,6656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6656,1,3,0)
 ;;=3^Cellulitis,Head (Except Face)
 ;;^UTILITY(U,$J,358.3,6656,1,4,0)
 ;;=4^L03.811
 ;;^UTILITY(U,$J,358.3,6656,2)
 ;;=^5009063
 ;;^UTILITY(U,$J,358.3,6657,0)
 ;;=L03.818^^42^482^12
 ;;^UTILITY(U,$J,358.3,6657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6657,1,3,0)
 ;;=3^Cellulitis,Oth Sites
 ;;^UTILITY(U,$J,358.3,6657,1,4,0)
 ;;=4^L03.818
 ;;^UTILITY(U,$J,358.3,6657,2)
 ;;=^5009064
 ;;^UTILITY(U,$J,358.3,6658,0)
 ;;=L03.891^^42^482^37
 ;;^UTILITY(U,$J,358.3,6658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6658,1,3,0)
 ;;=3^Lymphangitis,Head (Except Face),Acute
 ;;^UTILITY(U,$J,358.3,6658,1,4,0)
 ;;=4^L03.891
 ;;^UTILITY(U,$J,358.3,6658,2)
 ;;=^5009065
 ;;^UTILITY(U,$J,358.3,6659,0)
 ;;=L03.898^^42^482^38
 ;;^UTILITY(U,$J,358.3,6659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6659,1,3,0)
 ;;=3^Lymphangitis,Oth Sites,Acute
 ;;^UTILITY(U,$J,358.3,6659,1,4,0)
 ;;=4^L03.898
 ;;^UTILITY(U,$J,358.3,6659,2)
 ;;=^5009066
 ;;^UTILITY(U,$J,358.3,6660,0)
 ;;=L03.90^^42^482^13
 ;;^UTILITY(U,$J,358.3,6660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6660,1,3,0)
 ;;=3^Cellulitis,Unspec
 ;;^UTILITY(U,$J,358.3,6660,1,4,0)
 ;;=4^L03.90
 ;;^UTILITY(U,$J,358.3,6660,2)
 ;;=^5009067
 ;;^UTILITY(U,$J,358.3,6661,0)
 ;;=L03.91^^42^482^36
 ;;^UTILITY(U,$J,358.3,6661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6661,1,3,0)
 ;;=3^Lymphangitis,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,6661,1,4,0)
 ;;=4^L03.91
 ;;^UTILITY(U,$J,358.3,6661,2)
 ;;=^5009068
 ;;^UTILITY(U,$J,358.3,6662,0)
 ;;=M51.26^^42^482^34
 ;;^UTILITY(U,$J,358.3,6662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6662,1,3,0)
 ;;=3^Intervertebral Disc Displacement,Lumbar Region
 ;;^UTILITY(U,$J,358.3,6662,1,4,0)
 ;;=4^M51.26
 ;;^UTILITY(U,$J,358.3,6662,2)
 ;;=^5012249
 ;;^UTILITY(U,$J,358.3,6663,0)
 ;;=M51.27^^42^482^35
 ;;^UTILITY(U,$J,358.3,6663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6663,1,3,0)
 ;;=3^Intervertebral Disc Displacement,Lumbosacral Region
 ;;^UTILITY(U,$J,358.3,6663,1,4,0)
 ;;=4^M51.27
 ;;^UTILITY(U,$J,358.3,6663,2)
 ;;=^5012250
 ;;^UTILITY(U,$J,358.3,6664,0)
 ;;=G47.33^^42^482^53
 ;;^UTILITY(U,$J,358.3,6664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6664,1,3,0)
 ;;=3^Sleep Apnea,Obstructive
 ;;^UTILITY(U,$J,358.3,6664,1,4,0)
 ;;=4^G47.33
 ;;^UTILITY(U,$J,358.3,6664,2)
 ;;=^332763
 ;;^UTILITY(U,$J,358.3,6665,0)
 ;;=G44.1^^42^482^57
 ;;^UTILITY(U,$J,358.3,6665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6665,1,3,0)
 ;;=3^Vascular Headache NEC
 ;;^UTILITY(U,$J,358.3,6665,1,4,0)
 ;;=4^G44.1
 ;;^UTILITY(U,$J,358.3,6665,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,6666,0)
 ;;=R73.01^^42^482^32
 ;;^UTILITY(U,$J,358.3,6666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6666,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,6666,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,6666,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,6667,0)
 ;;=R74.8^^42^482^1
 ;;^UTILITY(U,$J,358.3,6667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6667,1,3,0)
 ;;=3^Abnormal Levels of Serum Enzymes
 ;;^UTILITY(U,$J,358.3,6667,1,4,0)
 ;;=4^R74.8
 ;;^UTILITY(U,$J,358.3,6667,2)
 ;;=^5019566
 ;;^UTILITY(U,$J,358.3,6668,0)
 ;;=R97.2^^42^482^19
 ;;^UTILITY(U,$J,358.3,6668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6668,1,3,0)
 ;;=3^Elevated Prostate Specific Antigen
 ;;^UTILITY(U,$J,358.3,6668,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,6668,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,6669,0)
 ;;=R03.0^^42^482^18
 ;;^UTILITY(U,$J,358.3,6669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6669,1,3,0)
 ;;=3^Elevated BP Reading w/o Diagnosis of HTN
 ;;^UTILITY(U,$J,358.3,6669,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,6669,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,6670,0)
 ;;=Z91.19^^42^482^44
 ;;^UTILITY(U,$J,358.3,6670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6670,1,3,0)
 ;;=3^Noncompliance w/ Medical Treatment/Regimen
 ;;^UTILITY(U,$J,358.3,6670,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,6670,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,6671,0)
 ;;=E66.01^^42^482^45
 ;;^UTILITY(U,$J,358.3,6671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6671,1,3,0)
 ;;=3^Obesity,Morbid
 ;;^UTILITY(U,$J,358.3,6671,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,6671,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,6672,0)
 ;;=H93.19^^42^482^56
 ;;^UTILITY(U,$J,358.3,6672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6672,1,3,0)
 ;;=3^Tinnitus,Unspec Ear
 ;;^UTILITY(U,$J,358.3,6672,1,4,0)
 ;;=4^H93.19
 ;;^UTILITY(U,$J,358.3,6672,2)
 ;;=^5006967
 ;;^UTILITY(U,$J,358.3,6673,0)
 ;;=G47.00^^42^482^33
 ;;^UTILITY(U,$J,358.3,6673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6673,1,3,0)
 ;;=3^Insomnia,Unspec
 ;;^UTILITY(U,$J,358.3,6673,1,4,0)
 ;;=4^G47.00
 ;;^UTILITY(U,$J,358.3,6673,2)
 ;;=^332924
 ;;^UTILITY(U,$J,358.3,6674,0)
 ;;=F43.10^^42^482^49
 ;;^UTILITY(U,$J,358.3,6674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6674,1,3,0)
 ;;=3^PTSD,Unspec
 ;;^UTILITY(U,$J,358.3,6674,1,4,0)
 ;;=4^F43.10
 ;;^UTILITY(U,$J,358.3,6674,2)
 ;;=^5003570
 ;;^UTILITY(U,$J,358.3,6675,0)
 ;;=F43.11^^42^482^47
 ;;^UTILITY(U,$J,358.3,6675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6675,1,3,0)
 ;;=3^PTSD,Acute
 ;;^UTILITY(U,$J,358.3,6675,1,4,0)
 ;;=4^F43.11
 ;;^UTILITY(U,$J,358.3,6675,2)
 ;;=^5003571
 ;;^UTILITY(U,$J,358.3,6676,0)
 ;;=F43.12^^42^482^48
 ;;^UTILITY(U,$J,358.3,6676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6676,1,3,0)
 ;;=3^PTSD,Chronic
 ;;^UTILITY(U,$J,358.3,6676,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,6676,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,6677,0)
 ;;=I25.119^^42^482^5
 ;;^UTILITY(U,$J,358.3,6677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6677,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/ Ang Pctrs,Unspec
 ;;^UTILITY(U,$J,358.3,6677,1,4,0)
 ;;=4^I25.119
 ;;^UTILITY(U,$J,358.3,6677,2)
 ;;=^5007111
 ;;^UTILITY(U,$J,358.3,6678,0)
 ;;=I25.10^^42^482^7
 ;;^UTILITY(U,$J,358.3,6678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6678,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,6678,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,6678,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,6679,0)
 ;;=I25.110^^42^482^6
 ;;^UTILITY(U,$J,358.3,6679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6679,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/ Unstable Ang Pctrs
 ;;^UTILITY(U,$J,358.3,6679,1,4,0)
 ;;=4^I25.110
 ;;^UTILITY(U,$J,358.3,6679,2)
 ;;=^5007108
 ;;^UTILITY(U,$J,358.3,6680,0)
 ;;=F17.219^^42^482^41
 ;;^UTILITY(U,$J,358.3,6680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6680,1,3,0)
 ;;=3^Nicotine Dependence,Cigarettes
 ;;^UTILITY(U,$J,358.3,6680,1,4,0)
 ;;=4^F17.219
 ;;^UTILITY(U,$J,358.3,6680,2)
 ;;=^5003369
 ;;^UTILITY(U,$J,358.3,6681,0)
 ;;=F17.299^^42^482^42
 ;;^UTILITY(U,$J,358.3,6681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6681,1,3,0)
 ;;=3^Nicotine Dependence,E-Cigarettes
 ;;^UTILITY(U,$J,358.3,6681,1,4,0)
 ;;=4^F17.299
 ;;^UTILITY(U,$J,358.3,6681,2)
 ;;=^5003379
 ;;^UTILITY(U,$J,358.3,6682,0)
 ;;=I25.810^^42^482^8
 ;;^UTILITY(U,$J,358.3,6682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6682,1,3,0)
 ;;=3^Athscl of CABG w/o Angina Pectoris
 ;;^UTILITY(U,$J,358.3,6682,1,4,0)
 ;;=4^I25.810
 ;;^UTILITY(U,$J,358.3,6682,2)
 ;;=^5007141
 ;;^UTILITY(U,$J,358.3,6683,0)
 ;;=R29.6^^42^482^22
 ;;^UTILITY(U,$J,358.3,6683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6683,1,3,0)
 ;;=3^Falls (Frequent)
 ;;^UTILITY(U,$J,358.3,6683,1,4,0)
 ;;=4^R29.6
 ;;^UTILITY(U,$J,358.3,6683,2)
 ;;=^5019317
 ;;^UTILITY(U,$J,358.3,6684,0)
 ;;=Z51.81^^42^483^17
 ;;^UTILITY(U,$J,358.3,6684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6684,1,3,0)
 ;;=3^Therapeutic Drug Level Monitoring
